| APR-246 induces early cell death by ferroptosis in acute myeloid leukemia R Birsen, C Larrue, J Decroocq, N Johnson, N Guiraud, M Gotanegre, ... Haematologica 107 (2), 403, 2021 | 145 | 2021 |
| Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein E Grignano, L Cantero-Aguilar, Z Tuerdi, T Chabane, R Vazquez, ... Cell Death Discovery 9 (1), 97, 2023 | 30 | 2023 |
| Tolerance of radiotherapy with concomitant glofitamab in diffuse large B cell lymphoma: a case report P Loap, N Johnson, R Birsen, J Decroocq, Y Kirova Strahlentherapie und Onkologie 200 (11), 983-985, 2024 | | 2024 |
| Proton Therapy Reduces the Effective Dose to Immune Cells in Mediastinal Hodgkin Lymphoma Patients P Loap, L De Marzi, J Decroocq, R Birsen, N Johnson, BD Fischer, ... International Journal of Particle Therapy 13, 100110, 2024 | | 2024 |
| Subcutaneous azacitidine maintenance in transplant-ineligible patients with acute myeloid leukemia: a single-center retrospective study N Johnson, M Templé, C Friedrich, L Willems, R Birsen, M Vignon, ... Haematologica 108 (10), 2850, 2023 | | 2023 |
| Prognostic impact of early minimal residual disease combined with complete molecular evaluation in acute myeloid leukemia with mutated NPM1: a single center … M Memoli, A Genthon, F Favale, S Lapusan, N Johnson, R Adaeva, ... Leukemia & Lymphoma 63 (9), 2171-2179, 2022 | | 2022 |
| PROGNOSTIC IMPACT OF MINIMAL RESIDUAL DISEASE AND COMPLETE MOLECULAR EVALUATION IN NPM1 MUTATED ACUTE MYELOID LEUKEMIA: A SINGLE CENTER STUDY M Memoli, A Genthon, F Favale, S Lapusan, N Johnson, R Adaeva, ... HAEMATOLOGICA 105, S93-S93, 2020 | | 2020 |
